HOND Valuation
HCM II Acquisition Corp
$
13.940
- Overview
- Forecast
- Valuation
- Earnings
HOND Relative Valuation
HOND's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HOND is overvalued; if below, it's undervalued.
Historical Valuation
HCM II Acquisition Corp (HOND) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of HCM II Acquisition Corp (HOND) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price：13.94
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
HCM II Acquisition Corp. (HOND) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
HCM II Acquisition Corp. (HOND) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
HCM II Acquisition Corp. (HOND) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
HCM II Acquisition Corp. (HOND) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
HCM II Acquisition Corp. (HOND) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
HCM II Acquisition Corp (HOND) has a current Price-to-Book (P/B) ratio of -38.89. Compared to its 3-year average P/B ratio of -31.75 , the current P/B ratio is approximately 22.48% higher. Relative to its 5-year average P/B ratio of -31.75, the current P/B ratio is about 22.48% higher. HCM II Acquisition Corp (HOND) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -0.10%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -0.10% , the current FCF yield is about -100.00% lower.
-38.89
P/B
Median3y
-31.75
Median5y
-31.75
-0.08
FCF Yield
Median3y
-0.10
Median5y
-0.10
Competitors Valuation Multiple
The average P/S ratio for HOND's competitors is 0.00, providing a benchmark for relative valuation. HCM II Acquisition Corp Corp (HOND) exhibits a P/S ratio of 0.00, which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of HOND increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of HOND in the past 1 year is driven by Unknown.
People Also Watch
FPH
Five Point Holdings LLC
6.140
USD
-1.44%
DSGN
Design Therapeutics Inc
6.350
USD
+4.96%
CDRO
Codere Online Luxembourg SA
6.820
USD
-1.87%
AVIR
Atea Pharmaceuticals Inc
2.930
USD
+1.74%
FORR
Forrester Research Inc
10.710
USD
-2.72%
ALDX
Aldeyra Therapeutics Inc
4.950
USD
+0.41%
DOMO
Domo Inc
18.200
USD
+0.78%
LANV
Lanvin Group Holdings Ltd
2.038
USD
-2.49%
SMTI
Sanara Medtech Inc
33.825
USD
+2.84%
ELMD
Electromed Inc
24.870
USD
+0.40%
FAQ
Is HCM II Acquisition Corp (HOND) currently overvalued or undervalued?
HCM II Acquisition Corp (HOND) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of HCM II Acquisition Corp (HOND) is between to according to relative valuation methord.
What is HCM II Acquisition Corp (HOND) fair value?
How does HOND's valuation metrics compare to the industry average?
What is the current P/B ratio for HCM II Acquisition Corp (HOND) as of Sep 23 2025?
What is the current FCF Yield for HCM II Acquisition Corp (HOND) as of Sep 23 2025?
What is the current Forward P/E ratio for HCM II Acquisition Corp (HOND) as of Sep 23 2025?